A comprehensive analysis of auditory event‐related potentials and network oscillations in an NMDA receptor antagonist mouse model using a novel wireless recording technology

por Schuelert, Niklas, Dorner‐Ciossek, Cornelia, Brendel, Michael, Rosenbrock, Holger
Publicado 2018

Optimization of Touchscreen-Based Behavioral Paradigms in Mice: Implications for Building a Battery of Tasks Taxing Learning and Memory Functions

por Delotterie, David, Mathis, Chantal, Cassel, Jean-Christophe, Dorner-Ciossek, Cornelia, Marti, Anelise
Publicado 2014

Targeting the dopamine D(1) receptor or its downstream signalling by inhibiting phosphodiesterase‐1 improves cognitive performance

por Pekcec, Anton, Schülert, Niklas, Stierstorfer, Birgit, Deiana, Serena, Dorner‐Ciossek, Cornelia, Rosenbrock, Holger
Publicado 2018

S31. ENHANCEMENT OF SYNAPTIC PLASTICITY BY COMBINATION OF PDE2 AND PDE9 INHIBITION PRESUMABLY VIA PRE- AND POST-SYNAPTIC MECHANISMS

por Rosenbrock, Holger, Kroker, Katja, Stierstorfer, Birgit, Hobson, Scott, Arban, Roberto, Dorner-Ciossek, Cornelia
Publicado 2020

M181. DEVELOPMENTAL PROGRESSION OF INTERNEURON NETWORK DEFICITS IN A 15Q13.3 MICRODELETION MOUSE MODEL – A GLIMPSE ON ADOLESCENT PRIMING FOR SCHIZOPHRENIA?

por Funk, Marzieh, Jaeger, Stefan, Schülert, Niklas, Dorner-Ciossek, Cornelia, Rosenbrock, Holger, Mack, Volker
Publicado 2020

S141. TRANSGENIC OVEREXPRESSION OF THE TYPE III ISOFORM OF NEUREGULIN 1 IN MICE INDUCES ABNORMALITIES ON AUDITORY EVENT RELATED EEG BIOMARKERS RELATED TO SCHIZOPHRENIA

por Rosenbrock, Holger, Nissen, Wiebke, Arban, Roberto, Moritz, Rossner, Markus, Schwab, Dorner-Ciossek, Cornelia, Schülert, Niklas
Publicado 2018

T178. MICROPIPETTE-GUIDED DRUG ADMINISTRATION (MDA) METHOD AS A NOVEL PHARMACOLOGICAL TREATMENT METHOD IN MICE: PRECLINICAL VALIDATION USING RISPERIDONE IN THE MATERNAL IMMUNE ACTI...

por Scarborough, Joseph, Müller, Flavia, Dorner-Ciossek, Cornelia, Arban, Roberto, Rosenbrock, Holger, Meyer, Urs, Richetto, Juliet
Publicado 2020

T40. GPR52 AGONISTS REPRESENT A NOVEL APPROACH TO TREAT UNMET MEDICAL NEED IN SCHIZOPHRENIA

por Grottick, Andrew J, Grayson, Ben, Podda, Giovanni, Idris, Nagi, Dorner-Ciossek, Cornelia, Neill, Joanna, Hobson, Scott
Publicado 2018

Symptomatic and preventive effects of the novel phosphodiesterase-9 inhibitor BI 409306 in an immune-mediated model of neurodevelopmental disorders

por Scarborough, Joseph, Mattei, Daniele, Dorner-Ciossek, Cornelia, Sand, Michael, Arban, Roberto, Rosenbrock, Holger, Richetto, Juliet, Meyer, Urs
Publicado 2021

Proteomic analysis reveals a biosignature of decreased synaptic protein in cerebrospinal fluid of major depressive disorder

por Al Shweiki, MHD Rami, Oeckl, Patrick, Steinacker, Petra, Barschke, Peggy, Dorner-Ciossek, Cornelia, Hengerer, Bastian, Schönfeldt-Lecuona, Carlos, Otto, Markus
Publicado 2020

Evaluation of Pharmacokinetics and Pharmacodynamics of BI 425809, a Novel GlyT1 Inhibitor: Translational Studies

por Rosenbrock, Holger, Desch, Michael, Kleiner, Oliver, Dorner‐Ciossek, Cornelia, Schmid, Bernhard, Keller, Sascha, Schlecker, Christina, Moschetti, Viktoria, Goetz, Sophia, Liesenfeld, Karl‐Heinz, Fillon, Gwenaelle, Giovannini, Riccardo, Ramael, Steven, Wunderlich, Glen, Wind, Sven
Publicado 2018